Bispecific Antibodies: what are they and are they the future of treatment for CLL (chronic lymphocytic leukemia)? Bispecific Antibodies: what are they and are they the future of treatment for CLL (chronic lymphocytic leukemia)?... June 24, 2020Beyond The BasicsBy Brad Hedrick
CLL Treatment Decision Tool The CLL Society worked with Clinical Care Options or CCO whose mission is “to improve clinical care and patient health... April 7, 2020How is Treatment Selected?By Brad Hedrick
Treatment Options for CLL From 5 Experts: An Online Tool CCO has partnered with the CLL Society to develop a treatment support tool to help you understand your treatment options.... April 3, 2020TreatmentBy Brad Hedrick
Things to Know About Acalabrutinib Getting a laboratory test result really has no meaning without having something with which to compare it. Its meaning comes... March 20, 2020Beyond The BasicsBy Brad Hedrick
ASH 2019: Dr. John Allan on Richter’s Transformation in CLL (chronic lymphocytic leukemia) Dr John Allan on new ways to target Richter’s Transformation.... January 19, 20202019 Conferences, Richter's TransformationBy Brad Hedrick
Normal Lab Values Getting a laboratory test result really has no meaning without having something with which to compare it. Its meaning comes... December 8, 2019Beyond The BasicsBy Brad Hedrick
EHA 2019: Dr. Matthew Davids On Richter’s Transformation in CLL (chronic lymphocytic leukemia) Great progress has been made in treating chronic lymphocytic leukemia, but sadly the outcomes for Richter’s Transformation (RT)) or Richter’s... November 4, 20192019 Conferences, Richter's TransformationBy Brad Hedrick
Cardiovascular side effects of Ibrutinib Dr. Farrukh Awan has done research on the cardiac side effects that have been increasingly reported with ibrutinib. He gives... October 23, 2019TreatmentBy Brad Hedrick
CD-20 targeting or not? Combining rituximab to venetoclax in relapsed chronic lymphocytic leukemia By Alan Skarbnik, MD The landscape of CLL is changing fast. Novel therapies and combinations are being studied and approved at a... September 16, 2019Beyond The BasicsBy Brad Hedrick
Biosimilars “Biosimilars” are equivalent versions of monoclonal antibodies that have previously been FDA approved to treat various diseases. Because antibodies are... August 11, 2019TreatmentBy Brad Hedrick
